TRDA - Balance Sheet - Entrada Therapeutics, Inc.

Current Liabilities	159 M
Accounts Payable	3.28 M
Short-Term Debt	14.9 M
Other Current Liabilities	141 M
Non-Current Liabilities	68 M
Long-Term Debt	60.3 M
Other Non-Current Liabilities	7.72 M

Millions

	Dec-2023	Dec-2022	Dec-2021	Dec-2020	Dec-2019
ASSETS
Cash & Cash Equivalents	67.6	45.2	291.1	39.0	16.8
Short Term Investments	284.4	143.6	0	0	0
Receivables	5.9	0	0	0	0
Inventory	0	0	0	0	0
Other Current Assets	11.9	21.2	7.6	0.9	0.6
Total Current Assets	369.8	209.9	298.7	39.9	17.4
PP&E	92.7	33.0	6.3	3.0	0.8
Intangible Assets	0	0	0	0	0
Goodwill	0	0	0	0	0
Long Term Investments	0	4.0	0	0	0
Other Long Term Assets	6.7	5.2	0.9	0.5	(0.8)
Other Assets	0	0	0	0	0
Total Assets	469.2	252.1	305.8	43.5	18.2
LIABILITIES
Accounts Payable	3.3	6.0	0.7	1.6	0.7
Short Term Debt	14.9	16.8	0	0	0
Other Current Liabilities	11.3	(0.8)	6.0	1.8	1.2
Total Current Liabilities	158.8	22.0	6.7	3.4	1.9
Long Term Debt	60.3	17.5	0	0	0
Deferred Tax Income	0	0	0	0	0
Other Liabilities	0	0	0.4	0	31.8
Total Liabilities	226.8	39.5	7.1	85.0	33.8
EQUITY
Common Stock	3 K	3 K	3 K	1 K	1 K
Retained Earnings	(195.0)	(188.3)	(93.7)	(42.5)	(16.0)
Other Accumulative Comprehensive Income/Loss	0.2	(2.1)	(305.8)	(81.7)	(31.8)
Total Equity	242.4	212.6	298.7	(41.5)	(15.5)
Total Liabilities and Equity	469.2	252.1	305.8	43.5	18.2
SHARES OUTSTANDING
Common Shares Outstanding	33.1	31.3	31.2	31.2	31.2

Free